Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-functioning pituitary adenomas.

P Chanson1, S Brochier

  • 1Service of Endocrinology and Reproduction Diseases, Bicetre University Hospital, Paris, France. philippe.chanson@bct.ap-hop-paris.fr

Journal of Endocrinological Investigation
|April 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Pituitary·2025
Same author

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

Pituitary·2025
Same author

Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE).

Pituitary·2024
Same author

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers.

Pituitary·2023
Same author

Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort.

Psychological medicine·2023
Same author

ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy.

European journal of endocrinology·2021
Same journal

lncRNA PANDAR predicts adverse pregnancy outcomes and reflects hyperglycemia-associated cellular stress in gestational diabetes mellitus.

Journal of endocrinological investigation·2026
Same journal

Correction: Early in, early out: reproductive lifespan timing and cardiometabolic risk in women.

Journal of endocrinological investigation·2026
Same journal

Adult mice are more susceptible to high-fat diet-induced visceral adiposity and insulin resistance than juvenile mice.

Journal of endocrinological investigation·2026
Same journal

Lactobacillus gasseri alleviates type 2 diabetes via modulation of gut microbiota-host metabolic networks.

Journal of endocrinological investigation·2026
Same journal

Rare causes of exogenous Cushing's Syndrome: a challenge for endocrinologists.

Journal of endocrinological investigation·2026
Same journal

Phase angle and triglyceride-glucose index as biomarkers of glycemic control, body composition and cardiovascular risk in adolescents with type 1 diabetes: a cross-sectional study.

Journal of endocrinological investigation·2026
See all related articles

Non-functioning pituitary adenomas (NFPAs), mostly gonadotroph-cell adenomas, cause mass effects and hormone deficiencies. Management involves observation, surgery, radiotherapy, or limited medical options, with surgery offering visual improvement but risk of relapse.

Area of Science:

  • Endocrinology
  • Neurosurgery
  • Oncology

Background:

  • Non-functioning pituitary adenomas (NFPAs) are predominantly gonadotroph-cell adenomas (>80%).
  • NFPAs typically present with mass effects (optic chiasm compression) or pituitary hormone deficiencies.
  • Elevated free alpha-subunit or LH-beta subunit levels are occasionally observed, but not typically dimeric LH/FSH.

Purpose of the Study:

  • To review the diagnostic and therapeutic strategies for non-functioning pituitary adenomas (NFPAs).
  • To evaluate the efficacy and outcomes of different management options for NFPAs.

Main Methods:

  • Literature review of diagnostic criteria and treatment outcomes for NFPAs.
  • Analysis of data regarding observation, transsphenoidal surgery, radiotherapy, and medical therapies.

Related Experiment Videos

Main Results:

  • Observation is suitable for small, asymptomatic, incidentally discovered adenomas.
  • Transsphenoidal surgery improves visual deficits in most patients but has a significant recurrence rate (approx. 30% within 5-10 years).
  • Radiotherapy reduces relapse rates but frequently causes hypopituitarism. Medical treatments (dopamine agonists, somatostatin analogs, GnRH analogs) show limited efficacy in tumor shrinkage or hormone normalization.

Conclusions:

  • Management of NFPAs requires a multimodal approach, balancing efficacy with potential side effects.
  • Surgery offers symptomatic relief but requires vigilant follow-up due to recurrence risk.
  • Radiotherapy is effective in preventing recurrence but carries the risk of long-term endocrine dysfunction. Medical therapies are generally disappointing for NFPA treatment.